Defining a case of invasive aspergillosis by serum galactomannan

被引：8

作者：

Maertens, Johan ^{[1
]}

Theunissen, Koen ^{[1
]}

Deeren, Dries ^{[1
]}

Meersseman, Wouter ^{[1
]}

Van Eldere, Johan ^{[1
]}

机构：

[1] Univ Hosp Gasthuisberg, Dept Haematol, B-3000 Louvain, Belgium

来源：

MEDICAL MYCOLOGY | 2006年 / 44卷

关键词：

galactomannan; sensitivity; neutropenia;

D O I：

10.1080/13693780600835732

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The timely diagnosis of invasive aspergillosis (IA) remains difficult. In recent years, increased experience has been gained with the Platelia (TM) Aspergillus enzyme immunoassay. However, the excellent sensitivity and high positive predictive value that has been reported in earlier studies cannot consistently be reproduced in some of the more recent studies. As expected, this stems from major methodological and clinical heterogeneities between studies. This article reviews these between-study heterogeneities and concludes that the detection of serum galactomannan can be used to define a case of IA in a well-defined population of at-risk patients.

引用

页码：S173 / S178

页数：6

共 36 条

[1] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
Ascioglu, S
Rex, JH
de Pauw, B
Bennett, JE
Bille, J
Crokaert, F
Denning, DW
Donnelly, JP
Edwards, JE
Erjavec, Z
Fiere, D
Lortholary, O
Maertens, J
Meis, JF
Patterson, TF
Ritter, J
Selleslag, D
Shah, PM
Stevens, DA
Walsh, TJ
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 7 - 14
[2] Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis
Balloy, V
Huerre, M
Latgé, JP
Chignard, M
[J]. INFECTION AND IMMUNITY, 2005, 73 (01) : 494 - 503
[3] PATHOGENESIS OF PULMONARY ASPERGILLOSIS - GRANULOCYTOPENIA VERSUS CYCLOSPORINE AND METHYLPREDNISOLONE-INDUCED IMMUNOSUPPRESSION
BERENGUER, J
ALLENDE, MC
LEE, JW
GARRET, K
LYMAN, C
ALI, NM
BACHER, J
PIZZO, PA
WALSH, TJ
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) : 1079 - 1086
[4] Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients
Bretagne, S
MarmoratKhuong, A
Kuentz, M
Latge, JP
BartDelabesse, E
Cordonnier, C
[J]. JOURNAL OF INFECTION, 1997, 35 (01) : 7 - 15
[5] CIMOLAI N, 2001, LAB DIAGNOSIS BACTER
[6] CORDONNIER C, 2006, BONE MARROW TRANSPL, P37
[7] SERODIAGNOSIS OF CANDIDIASIS, ASPERGILLOSIS, AND CRYPTOCOCCOSIS
DEREPENTIGNY, L
[J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 : S11 - S22
[8] Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients
Herbrecht, R
Letscher-Bru, V
Oprea, C
Lioure, B
Waller, J
Campos, F
Villard, O
Liu, KL
Natarajan-Amé, S
Lutz, P
Dufour, P
Bergerat, JP
Candolfi, E
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1898 - 1906
[9] Prospective assessment of Platelia™ Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients
Husain, S
Kwak, EJ
Obman, A
Wagener, MM
Kusne, S
Stout, JE
McCurry, KR
Singh, N
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 796 - 802
[10] Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked Immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders
Kawazu, M
Kanda, Y
Nannya, Y
Aoki, K
Kurokawa, M
Chiba, S
Motokura, T
Hirai, H
Ogawa, S
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) : 2733 - 2741

← 1 2 3 4 →